A new approach for treating schizophrenia
A new treatment for schizophrenia – backed by Wellcome-funded research – has been approved by the FDA and has the potential to change the lives of millions of people living with the condition globally.
Wellcome is a global charitable foundation. We want everyone to benefit from science’s potential to improve health and save lives.
We support discovery research into life, health and wellbeing, and we’re taking on three worldwide health challenges: mental health, infectious disease and climate and health.
A new treatment for schizophrenia – backed by Wellcome-funded research – has been approved by the FDA and has the potential to change the lives of millions of people living with the condition globally.
This policy brief identifies opportunities to drive change in how governments respond collaboratively to antimicrobial resistance (AMR). It is designed to support discussions with and between governments in the lead-up to and following the 2024 UN General Assembly.
Wellcome Collection is our free museum exploring health and human experience.
Wellcome Leap is a not-for-profit organisation set up by Wellcome to accelerate discovery and innovation for the benefit of human health.
Learn about our teams, our strategy and how we are funded.